Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00247390 · ClinicalTrials.gov registry record · Phase 3
Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.
A Phase 3 study, sponsored by Takeda.
- Completed
- Registry status
- Phase 3
- Development phase
- 451
- Enrollment target
NCT00247390: Completed Phase 3 study, sponsored by Takeda.
NCT00247390 is a Phase 3 study that has completed, run by Takeda. The registered enrollment target is 451 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (42% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00247390, a Phase 3 study, has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 451 participants
- Enrollment target
Study Summary
The purpose of this study to determine the long-term efficacy and safety of ramelteon, once daily (QD).
Interventions
- DRUG Placebo
- DRUG Ramelteon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 451 participants |
| Start Date | 2005-07 |
| Est. Completion | 2006-12 |
| Phase | Phase 3 |
What the finished NCT00247390 record still lists
NCT00247390 is an interventional study that assigns participants to a tested intervention. The registered 451 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (42% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00247390 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00247390 about?
NCT00247390 is a clinical study titled "Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.". The purpose of this study to determine the long-term efficacy and safety of ramelteon, once daily (QD).
What is the current status of trial NCT00247390?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 451 participants. The study started on 2005-07. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00247390?
The interventions under investigation include: Placebo (DRUG), Ramelteon (DRUG).
Who is sponsoring clinical trial NCT00247390?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00247390's enrollment target sits among peer trials
451 836th of 2000 higher than 1,164 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05676255 · 452 participants · Phase 2
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
- NCT05703178 · 452 participants · Phase 3
Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia